Mustang Bio
MBIO
73 hedge funds and large institutions have $45.9M invested in Mustang Bio in 2020 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 27 increasing their positions, 10 reducing their positions, and 7 closing their positions.
170% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 10
143% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 7
91% more capital invested
Capital invested by funds: $24M → $45.9M (+$21.9M)
14% more funds holding
Funds holding: 64 → 73 (+9)
0.01% more ownership
Funds ownership: 0.03% → 0.04% (+0.01%)
56% less call options, than puts
Call options by funds: $147K | Put options by funds: $334K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$6M |
| 2 |
ECM
Endurant Capital Management
San Mateo,
California
|
+$2.4M |
| 3 |
Millennium Management
New York
|
+$2.38M |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
+$1.21M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
+$1.16M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
-$675K |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
-$281K |
| 3 |
Renaissance Technologies
New York
|
-$217K |
| 4 |
BlackRock
New York
|
-$70.1K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$65.5K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
76
Simplex Trading
Chicago,
Illinois
| – | -$65.5K | -28 | Closed |
|
|
IWM
77
IHT Wealth Management
Chicago,
Illinois
| – | -$42K | -21 | Closed |
|
78
VOYA Investment Management
Atlanta,
Georgia
| – | -$42K | -21 | Closed |
|
79
Victory Capital Management
San Antonio,
Texas
| – | -$28K | -13 | Closed |
|
80
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$3K | -2 | Closed |
|
|
MAM
81
Meeder Asset Management
Dublin,
Ohio
| – | -$2K | -1 | Closed |
|
MBIO Hedge Fund Activity: Q2 2020 in Review
73 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Mustang Bio (MBIO) for Q2 2020, worth a combined $45.9M — up 91% from $24M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new MBIO positions and 7 closed out — a net gain of 10 holders — while 27 added to existing stakes and 10 trimmed.
The largest buyer was JP Morgan Chase, adding an estimated $6M. The largest seller was OrbiMed, exiting entirely with an estimated $675K sold.
- 73 institutional investors held Mustang Bio (MBIO) as of Q2 2020, up from 64 in Q1 2020.
- Funds reported $45.9M of Mustang Bio stock for Q2 2020, up 91% quarter-over-quarter.
- 17 funds opened new Mustang Bio positions in Q2 2020 and 7 closed out, a net change of +10 holders.
- The largest Mustang Bio buyer in Q2 2020 was JP Morgan Chase, an estimated $6M added.
- The largest Mustang Bio seller in Q2 2020 was OrbiMed, an estimated $675K sold.
Based on aggregated 13F filings for Q2 2020.